Occupational Exposure — Occupational Health Hazards Among Flour Mills Workers
Citation(s)
Abdullah AS, Driezen P, Quah AC, Nargis N, Fong GT Predictors of smoking cessation behavior among Bangladeshi adults: findings from ITC Bangladesh survey. Tob Induc Dis. 2015 Aug 11;13(1):23. doi: 10.1186/s12971-015-0050-y. eCollection 2015.
Brown CRH, Forster S, Duka T Goal-driven attentional capture by appetitive and aversive smoking-related cues in nicotine-dependent smokers. Drug Alcohol Depend. 2018 Sep 1;190:209-215. doi: 10.1016/j.drugalcdep.2018.06.011. Epub 2018 Jul 19.
Massin N, Bohadana AB, Wild P, Kolopp-Sarda MN, Toamain JP Airway responsiveness to methacholine, respiratory symptoms, and dust exposure levels in grain and flour mill workers in eastern France. Am J Ind Med. 1995 Jun;27(6):859-69.
Meo SA, Al-Drees AM Lung function among non-smoking wheat flour mill workers. Int J Occup Med Environ Health. 2005;18(3):259-64.
Nieva G, ComÃn M, Valero S, Bruguera E Cigarette dependence and depressive symptoms as predictors of smoking status at five-year follow-up after a workplace smoking cessation program. Addict Behav. 2017 Oct;73:9-15. doi: 10.1016/j.addbeh.2017.04.003. Epub 2017 Apr 3.
Wang CP, Ma SJ, Xu XF, Wang JF, Mei CZ, Yang GH The prevalence of household second-hand smoke exposure and its correlated factors in six counties of China. Tob Control. 2009 Apr;18(2):121-6. doi: 10.1136/tc.2008.024836. Epub 2009 Jan 8.
Occupational Health Hazards Among Flour Mills Workers And Smoking Situation Analysis Among Smokers, Assiut
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
